136 related articles for article (PubMed ID: 24324120)
1. Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.
Hayashi H; Okamoto I; Ueda S; Tanaka K; Okamoto K; Kawakami H; Nishina S; Takeda M; Fujisaka Y; Satoh T; Terao K; Nishimura Y; Doi K; Nakagawa K
Anticancer Res; 2013 Dec; 33(12):5699-705. PubMed ID: 24324120
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.
Kodaira T; Fuwa N; Tachibana H; Hidano S
Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma.
Sato D; Kogashiwa Y; Tsukahara K; Yamauchi K; Kohno N
Chemotherapy; 2013; 59(4):314-8. PubMed ID: 24480865
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
Kogashiwa Y; Yamauchi K; Nagafuji H; Matsuda T; Tsubosaka T; Karaho T; Maruyama T; Kohno N
Chemotherapy; 2010; 56(6):453-8. PubMed ID: 21088397
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.
Tanaka Y; Yoshida K; Osada S; Yamaguchi K; Takahashi T
Anticancer Res; 2011 Dec; 31(12):4589-97. PubMed ID: 22199335
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Ohashi T; Ohnishi M; Tanahashi S; Murai M
Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Fujii M; Tomita K; Nishijima W; Tsukuda M; Hasegawa Y; Ishitoya J; Yamane H; Homma A; Tomita T
Jpn J Clin Oncol; 2010 Mar; 40(3):214-21. PubMed ID: 19934112
[TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
[TBL] [Abstract][Full Text] [Related]
11. [Effects of concurrent S-1, nedaplatin/radiation therapy for 5 cases of head and neck cancer with esophageal carcinoma].
Shimane T; Mori T; Ono T; Egawa S; Furuya A; Kobayashi S; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1349-52. PubMed ID: 20647725
[TBL] [Abstract][Full Text] [Related]
12. [Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
Takemura H; Kobayashi S; Katsuno M; Asano R; Morimoto M; Tachibana S; Kubota H; Iida M; Kadokura Y; Sanbe T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2065-9. PubMed ID: 16352930
[TBL] [Abstract][Full Text] [Related]
13. [Combination therapy with S-1 and CDDP for head and neck cancer].
Fujii M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():150-4. PubMed ID: 16897992
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors.
Chung KY; Saito K; Zergebel C; Hollywood E; Segal M; Saltz LB
Oncology; 2011; 81(2):65-72. PubMed ID: 21968463
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer.
Park I; Lee JL; Ryu MH; Chang HM; Kim TW; Sym SJ; Lee SS; Jang G; Yoo C; Bae KS; Kang YK
Cancer Chemother Pharmacol; 2010 Feb; 65(3):473-80. PubMed ID: 19551382
[TBL] [Abstract][Full Text] [Related]
16. A single-institute phase I/II trial combining nedaplatin dose escalation with a fixed dose of docetaxel for induction chemotherapy of oral squamous cell carcinoma.
Miyazaki A; Kobayashi J; Yamamoto T; Kido Y; Takemura K; Abe M; Tomihara K; Dehari H; Nakamori K; Nagai I; Hiratsuka H
Oral Oncol; 2008 May; 44(5):471-6. PubMed ID: 17826308
[TBL] [Abstract][Full Text] [Related]
17. Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer.
Fujitani K; Narahara H; Takiuchi H; Tsujinaka T; Satomi E; Gotoh M; Hirao M; Furukawa H; Taguchi T
Oncology; 2005; 69(5):414-20. PubMed ID: 16319513
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.
Yoshida K; Hirabayashi N; Takiyama W; Ninomiya M; Takakura N; Sakamoto J; Nishiyama M; Toge T
Anticancer Res; 2004; 24(3b):1843-51. PubMed ID: 15274365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
